Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Syros Pharmaceuticals, Inc. - Common Stock (NQ:SYRS)

0.1172 UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Syros Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
A Look Into Healthcare Sector Value Stocks ↗
 
Via Benzinga
News headline image
Overview Of Value Stocks In The Healthcare Sector ↗
 
Via Benzinga
News headline image
3 Once-in-a-Lifetime Penny Stocks With Unprecedented Surge Potential ↗
Is your portfolio is in dire need of making new all-time highs? A new economic cycle is to send these penny stocks with potential up. 
Via InvestorPlace
News headline image
5 Value Stocks To Watch In The Healthcare Sector ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Preview: Syros Pharmaceuticals's Earnings ↗
 
Via Benzinga
News headline image
Earnings Outlook For Syros Pharmaceuticals ↗
 
Via Benzinga
News headline image
Syros Pharmaceuticals: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
Syros Pharmaceuticals's Earnings Outlook ↗
 
Via Benzinga
News headline image
Syros Pharmaceuticals's Return On Capital Employed Overview ↗
 
Via Benzinga
News headline image
5 Value Stocks To Watch In The Healthcare Sector ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Why Is Blood Cancer Focused Syros Pharmaceuticals Stock Soaring Today? ↗
Syros Pharmaceuticals Inc (NASDAQ: SYRS) released initial data from its ongoing SELECT-AML-1 Phase 2 trial of tamibarotene in combination with venetoclax and azacitidine in newly diagnosed, unfit... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Small Stakes, Big Rewards: 3 Penny Stocks with 300% Upside Potential ↗
Although even so-called penny stocks with potential carry dramatic risks, these four-baggers benefit from analyst backing. 
Via InvestorPlace
News headline image
Syros Pharmaceuticals's Earnings Outlook ↗
 
Via Benzinga
Analyst Expectations for Syros Pharmaceuticals's Future ↗
 
Via Benzinga
Syros Pharmaceuticals's Return On Capital Employed Overview ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Pfizer To Terminate Development Pact With Syros Pharmaceuticals For Novel Therapies For Two Blood Disorders ↗
Syros Pharmaceuticals Inc received notice from Pfizer Inc (NYSE: PFE), as successor to Global Blood Therapeutics Inc, exercising its right to terminate the License and Collaboration Agreement dated... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  On Friday, 93 stocks made new 52-week lows. 
Via Benzinga
News headline image
Tesla To Rally Around 15%? Here Are 10 Other Analyst Forecasts For Friday ↗
Credit Suisse cut the price target for Hormel Foods Corporation (NYSE: HRL) from $44 to $41. Credit Suisse analyst Robert Moskow maintained a Neutral rating. Hormel Foods shares fell 1.7% to $41.13 in... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 298 companies achieved new lows for the year. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  On Monday, 297 companies reached new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 14, 2022 ↗
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.